Share This

Related Topics News - Drugs

     
 < Previous page   Detail   |   Print    Next page > 
     
石藥集團抗體藥JMT203獲美FDA批准開展臨床研究
2025-04-22T  
金斯瑞上季CARVYKTI貿易銷售淨額3.69億美元 按季升10.5%
2025-04-16T  
石藥集團磷酸奧司他韋乾混懸劑獲藥品註冊批件
2025-04-15T  
石藥抗體偶聯藥物SYS 6041美國臨床試驗獲批
2025-04-14T  
石藥集團SYH2046片獲准開展臨床試驗
2025-04-13T  
《大行》里昂:美關稅政策對中國醫療保健行業影響相對較小
2025-04-09T  
石藥集團I類新藥JMT108獲美國臨床試驗批准
2025-04-09T  
《大行》大和降石藥目標價至5元 維持「持有」評級
2025-04-08T  
美國家衛生研究院禁止中國訪問基因及疾病數據庫 醫藥股顯著下滑
2025-04-07T  
《大行》華泰證券降國藥控股目標價至22.54元 去年純利遜預期
2025-04-03T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.